JENNIFER LEE

Profile

First Name

: JENNIFER

Middle Name

:

Last Name

: LEE

Related Companies

Titles

Company Name

Related People

DIRECTOR

DERMBIONT, INC.

STEVEN BASTA, KARL R BEUTNER, KARL R. BEUTNER, ROBERT BRUCKER, MAX DAWSON, NICHOLA ELIOVITS, WILDER RAMSEY, RAMSEY WILDER, DANIEL YADEGAR

EXECUTIVE OFFICER

T.Y.LIN INTERNATIONAL GROUP, LTD.

MATTHEW G. CUMMINGS, WILLIAM K. HARNAGEL, PHILLIP L. HARRISON, SHEILA JORDAN, RAYMOND H. LAHOOD, PEN ANN KENNY LIM, IAN MACLEOD, NIEK NIENS, WILLIAM H. OVERTURF, THOMAS J. PRICE, BASHAR RIHANI, SUSAN DIAZ SONNEFELDT, JOHN YOUNG

EXECUTIVE OFFICER

LEEGEN INVESTMENT LLC

JENNIFER J. LEE, TOMMY LEE

EXECUTIVE OFFICER, DIRECTOR

K1X CO-INVEST, LLC

N/A EDISON PARTNERS X, LP, JOE GIQUINTO

DIRECTOR

ADDITION THERAPEUTICS, INC.

PETER BISGAARD, KATHLEEN COLLINS, LAWRENCE KONG, RONALD PARK, MATTHEW PATTERSON, JAYSON PUNWANI, LAETITIA SCHWAB

Filings

Filing Date

Filing Type

Source URL

Industry Classifier

Detailed Industry

Revenue Range

Securities

First Sale Date

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Debt

2025-12-11

D

OTHER

DECLINE TO DISCLOSE

Equity

2024-09-30

D

POOLED INVESTMENT FUND

Equity

2024-09-05

D

OTHER

DECLINE TO DISCLOSE

Equity

2024-06-17

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Debt

2023-03-06

D

OTHER

DECLINE TO DISCLOSE

Equity

2022-11-25

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Debt

2022-09-06

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2021-12-30

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2021-12-17

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2021-08-04